The European Commission's new Delegated Regulation (EU) 2022/1518 adds two drug precursors to the list of scheduled substances. The regulation entered into force on 3 October 2022.
Due to concerns about the risk of anaphylactic reactions, the dispensation of pholcodine-containing medicinal products is suspended from 1 October 2022.
There is limited availability of the medicine Ozempic (semaglutide-based solution for subcutaneous injection) due to an acute increase in demand. This limited availability will certainly last until early 2023. Experts from the FAMHP's Unavailability Task Force give recommendations.
The FAMHP wants to warn consumers in Belgium not to use TKTX ointment, an illegal pain-relieving cream. It is mainly used to alleviate pain when applying a tattoo, permanent make-up ... TKTX ointment is not licensed in Belgium or Europe and therefore no guarantees can be given with regard to the composition, safety, quality or efficiency of this illegal medicine.
During the September 2022 meeting, the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) has started a referral of topiramate and also started a referral of pholcodine medicines.
Since the beginning of 2022, there has been an increase in the incidence of anaphylactic-type reactions in cattle after administration of HIPRABOVIS IBR MARKER LIVE vaccine. The cause has not yet been clearly identified and investigations are ongoing. Veterinarians are asked to report any adverse reactions as soon as possible and, if possible, to provide a complete history of vaccinations and an overview of other veterinary medicinal products previously used.
The European Commission has launched a call for laboratories of Member States to apply to become European Union reference laboratories (EURLs) for in vitro diagnostic (IVD) medical devices. The possible designation of such EURLs is provided for in article 100 of the Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR).
In order to prevent the spread of West Nile virus through contaminated blood or human body material, candidate donors from areas where autochthonous cases are found must wait before donating. From now until the end of November, the FAMHP will provide weekly updates on the affected areas. This weekly update is based on data from the European Centre for Disease Prevention and Control (ECDC).